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Background: Renal insufficiency has been correlated with less favorable outcomes following revascularization by either coronary artery bypass 
surgery (CABG) or percutaneous coronary intervention (PCI) in patients with ischemic heart disease, but few studies have compared outcomes in 
these patients according to the method of revascularization.
Methods: In the prospective SYNTAX trial, patients with de novo LM and/or 3VD disease were randomized to either PCI or CABG if deemed suitable 
upon screening for either treatment option by consensus of a cardiac surgeon and an interventional cardiologist. Glomerular filtration rate (GFR) was 
calculated using the Modification of Diet in Renal Disease (MDRD) formula. Outcomes at 2 years were analyzed posthoc by baseline GFR of <15, 
15-29, 30-59, 60-89, and ≥90 mL/min/1.73m2.
Results: Among 1,800 randomized patients, GFR could be calculated for 1,638 patients (CABG 786, TAXUS 852); of these, 264 (16%) had 
evidence of chronic kidney disease (GFR <60 mL/min/1.73m2), and 930 (57%) had decreased GFR (60-89 mL/min/1.73m2). Rates and odds 
ratios by multivariate analysis for outcomes by baseline GFR are given below (Table).
Conclusion: Baseline GFR significantly predicted all-cause death but not MACCE; however, multivariate analysis did not demonstrate a treatment 
interaction for 2-year outcomes following revascularization with either PCI or CABG. 
Two-Year Outcomes In Patients Treated With Either PCI or CABG According to Baseline Glomerular Filtration Rate
Rates of 2-year Outcomes by Baseline Glomerular Filtration Rate Category














MACCE 15.6% 27.4%* 15.5% 23.7%* 18.1% 20.8%
Death/CVA/MI 13.2% 17.7% 8.9% 9.8% 8.3% 8.6%
Death 9.9% 11.8% 4.0% 5.3% 2.8% 4.1%
Stroke 2.6% 3.3% 3.3% 1.1%* 2.4% 1.4%
MI 3.3% 6.9% 2.5% 5.4%* 4.5% 6.8%
Revasc 5.0% 14.9%* 8.1% 18.0%* 12.9% 18.3%
ST/GO 1.7% 0.8% 2.4% 3.9% 2.8% 4.6%
*P<0.05
Odds Ratios and 95% CI for Multivariate Analysis of Outcomes by Baseline Glomerular Filtration Rate
Parameter CABG PCI Overall Interaction P value
MACCE 1.00 (0.99, 1.01) 0.99 (0.99, 1.00) 1.00 (0.99, 1.00) 0.09
Death/CVA/MI 0.99 (0.98, 1.00) 0.99 (0.98, 1.00)* 0.99 (0.98, 1.00)* 0.72
Death 0.98 (0.96, 0.99)* 0.98 (0.97, 0.99)* 0.98 (0.97, 0.99)* 0.82
Stroke 1.00 (0.98, 1.02) 0.99 (0.96, 1.02) 1.00 (0.98, 1.01 0.59
MI 1.01 (0.99, 1.03) 1.00 (0.99, 1.01 1.00 (0.99, 1.01) 0.51
Revas 1.01 (1.00, 1.02)* 1.00 (0.99, 1.01) 1.00 (1.00, 1.01) 0.07
ST/GO 1.00 (0.98, 1.02) 1.01 (0.99, 1.02) 1.00 (0.99, 1.02) 0.68
*P<0.05
CVA=cerebrovascular event; GO=graft occlusion; LM=left main; MACCE=major adverse cardiovascular events; MI=myocardial infarction; ST=stent thrombosis; 3VD=three vessel disease
